Markedly-elevated serum CA125 in a woman with pulmonary tuberculosis

Singapore Medical Journal

Volumn 50, Issue 1, 2009, Pages

  Sulaiman, S ^a   Tan, K H ^a,b  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^b Department of Perinatal Audit and Epidemiology ^*  (Singapore)

Author keywords

Cancer antigen 125; Health screening; Pulmonary tuberculosis; Tuberculosis

Indexed keywords

AFP ANTIGEN; BHCG ANTIGEN; CA 125 ANTIGEN; CA 199 ANTIGEN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FEMALE; HUMAN; LUNG TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; CA-125 ANTIGEN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; TUBERCULOSIS, PULMONARY;

EID: 62649113423     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Nakanishi Y, Hiura K, Katoh O, et al. [Clinical signifcance of serum CA125 in patients with tuberculous pleurisy]. Kekkaku 1991; 66:525-30. Japanese.
2. Tan KH, Koh CH, Chew S Y, Yo SL. Preoperative evaluation of serum CA125 in patients with a pelvic mass. Singapore J Obstet Gynaecol 1992; 23:51-8.
3. Tongsong T, Sukpan K, Wanapirak C, Sirichotiyakul S, Tongprasert F. Sonographic features of female pelvic tuberculous peritonitis. J Ultrasound Med 2007; 26:77-82.
4. Sevinc A, Camci C, Turk HM, Buyukberber S. How to interpret serum CA125 levels in patients with serosal involvement? A clinical dilemma. Oncology 2003; 65:1-6.